Burning Rock Biotech Ltd (BNR) stock
BNRNasdaqServices-Medical Laboratories
$12.50−0.24 (-1.88%)
Close on Nov 17, 2026Market cap $136.07MP/E –Yield –
Burning Rock Biotech cash
Cash and short-term investments held at the end of each period.
Burning Rock Biotech's cash was CN¥478.39M at Dec 31, 2025. For fiscal 2025 it was CN¥478.39M, down 8.0% from the year before. The highest annual figure on record is CN¥2.29B in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | CN¥478.39M | -8.0% |
| FY2024 | Dec 31, 2024 | CN¥519.85M | -15.5% |
| FY2023 | Dec 31, 2023 | CN¥615.10M | -33.5% |
| FY2022 | Dec 31, 2022 | CN¥925.27M | -38.4% |
| FY2021 | Dec 31, 2021 | CN¥1.50B | -34.3% |
| FY2020 | Dec 31, 2020 | CN¥2.29B | +454.9% |
| FY2019 | Dec 31, 2019 | CN¥412.23M | +332.4% |
| FY2018 | Dec 31, 2018 | CN¥95.33M | +74.0% |
| FY2017 | Dec 31, 2017 | CN¥54.79M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | CN¥478.39M | -58.3% |
| Q4 FY2024 | Dec 31, 2024 | CN¥519.85M | -65.4% |
| Q4 FY2023 | Dec 31, 2023 | CN¥615.10M | -66.8% |
| Q4 FY2022 | Dec 31, 2022 | CN¥925.27M | -59.5% |
| Q2 FY2022 | Jun 30, 2022 | CN¥1.15B | +178.6% |
| Q4 FY2021 | Dec 31, 2021 | CN¥1.50B | +1476.4% |
| Q2 FY2021 | Jun 30, 2021 | CN¥1.85B | +3281.9% |
| Q4 FY2020 | Dec 31, 2020 | CN¥2.29B | – |
| Q4 FY2019 | Dec 31, 2019 | CN¥412.23M | – |
| Q4 FY2018 | Dec 31, 2018 | CN¥95.33M | – |
| Q4 FY2017 | Dec 31, 2017 | CN¥54.79M | – |
See a number that looks wrong?